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Edited by Peter BrzezinskiAbstract Xestospongin B, a macrocyclic bis-1-oxaquinolizi-
dine alkaloid extracted from the marine sponge Xestospongia
exigua, was highly puriﬁed and tested for its ability to block
inositol 1,4,5-trisphosphate (IP3)-induced Ca
2+ release. In a
concentration-dependent manner xestospongin B displaced
[3H]IP3 from both rat cerebellar membranes and rat skeletal
myotube homogenates with an EC50 of 44.6 ± 1.1 lM and
27.4 ± 1.1 lM, respectively. Xestospongin B, depending on
the dose, suppressed bradykinin-induced Ca2+ signals in neuro-
blastoma (NG108-15) cells, and also selectively blocked the
slow intracellular Ca2+ signal induced by membrane depolar-
ization with high external K+ (47 mM) in rat skeletal myotu-
bes. This slow Ca2+ signal is unrelated to muscle contraction,
and involves IP3 receptors. In highly puriﬁed isolated nuclei
from rat skeletal myotubes, Xestospongin B reduced, or sup-
pressed IP3-induced Ca
2+ oscillations with an EC50 = 18.9 ±
1.35 lM. In rat myotubes exposed to a Ca2+-free medium,
Xestospongin B neither depleted sarcoplasmic reticulum Ca2+
stores, nor modiﬁed thapsigargin action and did not aﬀect
capacitative Ca2+ entry after thapsigargin-induced depletion
of Ca2+ stores. Ca2+-ATPase activity measured in skeletal
myotube homogenates remained unaﬀected by Xestospongin
B. It is concluded that xestospongin B is an eﬀective cell-per-
meant, competitive inhibitor of IP3 receptors in cultured rat
myotubes, isolated myonuclei, and neuroblastoma (NG108-
15) cells.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Xestospongins are a group of macrocyclic bis-1-oxaquino-
lizidines alkaloids isolated from marine sponges [1–6]. These*Corresponding author. Fax: +33 169 82 41 41.
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doi:10.1016/j.febslet.2005.02.053compounds have been described to be potent membrane-per-
meable inhibitors of inositol 1,4,5-trisphosphate (IP3)-medi-
ated Ca2+ release from endoplasmic reticulum stores [7,8].
Although various compounds of the xestospongins family
were reported to inhibit IP3-dependent processes in distinct cell
types [7,9], their use has been mainly limited to xestospongin C
(XeC) [10–13].
The precise site of action for xestospongins at the cellular
level remains elusive. In fact, XeC was reported to block
IP3-mediated Ca
2+ signalling without interacting with the
IP3-binding site, since the alkaloid did not aﬀect the ability
of [3H]IP3 to bind to cerebellar microsomes [7]. Further-
more, several reports provided evidence indicating that
XeC lacks speciﬁcity, and acts by inhibiting the calcium
pump in smooth muscle [14], cultured dorsal root ganglia
neurons [15] and Schwann cells of the neuromuscular junc-
tion in situ [16]. In neuronal cells, IP3 is known to exert
an important second messenger role in the release of Ca2+
from intracellular stores in response to membrane-receptor
activation (for a review see [17]). Furthermore, recent stud-
ies suggest a role for IP3 receptors in complex spatial
and temporal intracellular Ca2+ signals in cultured skeletal
muscle cells, and mature mouse neuromuscular junctions
[18–23].
The purpose of the present study was to test the speciﬁc-
ity, the site of action and the ability of Xestospongin B
(XeB) (Fig. 1), to block IP3-mediated Ca
2+ signalling. For
this purpose, binding studies were carried out ﬁrst, in both
rat cerebellum membranes, and myotube homogenates. Sec-
ond, we tested the ability of XeB to block bradykinin-
induced increase of intracellular Ca2+ levels in diﬀerentiated
rodent neuroblastoma (NG108-15) cells. Bradykinin has
been shown in NG108-15 cells to increase the degradation
of phosphatidylinositol-4,5-bisphosphate leading to the pro-
duction IP3 and diacylglycerol [24]. Third, we tested the ef-
fect of XeB in rat myotubes, where the involvement of IP3
receptors in the generation of a slow intracellular Ca2+ tran-
sient involved in the regulation of gene expression has been
described [18,19,23,25]. Finally, we investigated the ability of
XeB to aﬀect Ca2+ signals in highly puriﬁed isolated
myonuclei.blished by Elsevier B.V. All rights reserved.
Fig. 1. Chemical structure of XeB and XeC. Note that XeB diﬀers
from XeC by the stereochemistry of the two cis-oxaquinolizide rings
(cis and trans in XeC). XeB also bears a hydroxyl group on one of the
oxaquinolizide rings, and a methyl on the other one.
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2.1. Cell cultures
Mouse neuroblastoma · rat glioma NG108-15 hybrid cells were
grown in Dulbeccos modiﬁed Eagles medium (DMEM) supple-
mented with 5% fetal calf serum, 100 lM hypoxanthine, 0.4 lM
aminopterin, 16 lM thymidine, 2 mM glutamine, 3 lM glycine,
100 IU/ml penicillin and 100 lg/ml streptomycin. The cultures were
maintained at 37 C in a humidiﬁed atmosphere containing 95%
air–5% CO2. Cells were seeded on sterile glass coverslips placed in
plastic dishes (35 mm) at a density of 30 · 103 cells per dish. Cells
were diﬀerentiated by reducing to 1% fetal calf serum and adding
0.5 lM dibutyryl-cyclic-adenosine-monophosphate (Sigma–Aldrich
Chimie, Saint Quentin Fallavier, France). This medium maintained
cell diﬀerentiation for 1–5 days.
Neonatal rat skeletal muscle cells in primary culture were prepared
as follows: myoblasts were obtained from posterior hind limbs of
12–24 h-old new-born rats. After dissection, the tissue was mechani-
cally dispersed and then treated with 0.2% (w/v) collagenase type IV
(Sigma) for 15 min at 37 C under mild agitation. The suspension
was ﬁltered through nytex membranes or lens tissue paper and spun
down at low speed. After a 10–15 min pre-plating on a 150 mm dish
to partially eliminate the faster sedimenting ﬁbroblasts, cells were pla-
ted on round coverslips at a density of ca. 350 · 103 per dish (35 mm).
Culture medium was DMEM/F12, 10% bovine serum, 2.5% fetal calf
serum, 100 mg/l penicillin, 50 mg/l streptomycin and 2.5 mg/l ampho-
terycin B. To eliminate remaining ﬁbroblasts, 10 lM cytosine arabino-
side (Sigma) was added at the 3rd day of culture for 36 h. Then, the
medium was replaced by a cytosine arabinoside-free medium contain-
ing 1.8% fetal calf serum concentration. Myotubes after the 5th day of
culture had an estimated purity of more than 90%.
2.2. Myonuclei isolation
Highly puriﬁed myonuclei were obtained by the combined use of a
hypotonic shock and mechanical disruption in a Dounce homogenizer,
as previously reported [26]. Brieﬂy, myotubes (10 · 106) were washed
in phosphate-buﬀered saline (PBS), and incubated in 0.1% (v/v) trypsin
(Sigma) for 20 min at 25–30 C and later scrapped oﬀ using a rubber
policeman. Cells were spun down at 4000 · g (Heraus Biofuge 15R)
to eliminate the trypsin. The resulting cell pellet was suspended in
hypotonic buﬀer containing 10 mM Tris–HCl, pH 7.8, 10 mM b-
mercaptoethanol, 0.5 mM phenylmethylsulfonyl ﬂuoride (Calbio-
chem), 1 lg ml1 aprotinin, leupeptin and pepstatin (Calbiochem).
After 2–3 min in ice the swollen cells were broken in a Dounce homog-
enizer. The nuclear pellet was obtained by centrifugation at 500 · g for
6 min at 4 C, and washed in 10 mM Tris–HCl, pH 7.2, 2 mM MgCl2
plus protease inhibitors. Finally, the nuclear pellet was resuspended in
10 mMHEPES–Tris, pH 7.6, 110 mMKCl, 1 mMMgCl2 and the pro-
tease inhibitors. Nuclear integrity was routinely checked by electron
and confocal microscopy, both in unstained and acridine orange
(2.5% v/v; Sigma) stained samples, as will be published elsewhere.2.3. [3H]IP3 binding assays
Equilibrium competition assays were performed using increasing
concentrations of XeB (0.1–100 lM) both in the absence and in
the presence of a constant low concentration of tritiated IP3
([3H]IP3) in the reaction medium, as described previously [19]. Cer-
ebellar membrane vesicles were incubated 30 min at 4 C in 50 mM
Tris–HCl (pH 8.4) containing 1 mM EDTA, 2 mM b-mercap-
toethanol, and 1.6 nM of [3H]IP3 (22 Ci/mmol, American Radiola-
belled Chemicals Inc., USA). Myotubes homogenates were
incubated at 4 C for 30–40 min in a medium containing 50 mM
Tris–HCl (pH 8.4), 1 mM EDTA, and 2 mM b-mercaptoethanol.
50 nM (from a 1 lM stock) of [3H]IP3 (D-myo-[2-3H]inositol 1,4,5-
trisphosphate, speciﬁc activity 21.0 Ci/mmol; NEN-Dupont; 800–
1000 cpm/pmol). The suspensions were centrifuged (Heraus Biofuge
15R) at 10000 · g for 10 min, the supernatant was aspired, and
the pellets were washed with PBS, and dissolved in NaOH (1 M).
The [3H]IP3 radioactivity remaining bound to the membranes was
measured by liquid scintillation. Non-speciﬁc binding was deter-
mined in the presence of 1–2 lM IP3 (Sigma).
Competition binding experiments were analyzed by the Prism soft-
ware (GraphPad Software Inc., USA) using a non-linear Hill equa-
tion for EC50 determination (the concentration of competitor that
competes for half the speciﬁc binding). The concentration of the
competing ligand that will bind to half the binding sites at equilib-
rium, in the absence of radioligand, or other competitors (Ki values)
were calculated by the Cheng and Prusoﬀ equation (Ki = EC50/
(1 + ([ligand\]/Kd), where [ligand
\] is the concentration of the hot
ligand) [27].
2.4. Calcium signal measurements
NG108-15 cells were incubated for 45 min with 4 lM ﬂuo-3/AM
(Molecular Probes Europe, The Netherlands) in standard solution
(containing in mM: 154 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 5 HEPES,
and 11 glucose, pH 7.4) at 25 C. After ﬂuo-3/AM was loaded into
cells, the dye was washout from the medium and the coverslips con-
taining the cells were transferred to a recording chamber (1.5 ml vol-
ume). Ca2+ signals were imaged with an upright microscope
equipped with an epiﬂuorescence unit and an extended ISIS cooled
CCD, video camera (Photonics Science, UK). For video imaging, illu-
mination was provided by a quartz-halogen bulb (12 V/100 W) and
ﬂuorescence recorded through a plan 40· (0.7 numerical aperture)
long-working-distance, water-immersion lens, using an interference
set of ﬁlters (excitation: 485 nm; emission: 535 nm) and a dichroic mir-
ror (505 nm), as previously reported [28]. Digitizing and analysis of
ﬂuorescence images was performed using a frame grabber (DT-3155,
Data Translation, USA) and imaging workbench 2.1 software (Axon
Instruments, Union City, CA, USA).
For measuring intracellular Ca2+ signals in rat myotubes, the cells
were pre-incubated in a resting solution of the following composition
(in mM): 145 NaCl, 5 KCl, 2.6 CaCl2, 1 MgCl2, 10 Na HEPES and
5.6 glucose (pH 7.4), containing 5.4 lM ﬂuo-3/AM for 30 min at
25 C. Cells attached to coverslips were placed in a perfusion chamber
(1 ml capacity) and mounted on an inverted ﬂuorescence microscope
(Olympus, Japan). Images were acquired with a cooled CCD camera
(Spectra-Source MCD 600, USA). A ﬁlter wheel (Lambda-10-2, Sutter
Instrument Co, USA) was used as a shutter in order to avoid unneces-
sary light exposure to the cells. The ﬂuorescent images were collected
every 0.1–2.0 s and analyzed frame by frame. Cells were depolarized
by a fast perfusion system using a high K+ (47 mM) isotonic solution.
Images from each experiment were processed identically by outlining
the cells ﬂuorescence and determining their mean ﬂuorescence before
(F0) and during various treatments (F). The relative ﬂuorescence
(DF/F0) was calculated as (F  F0)/F0.
Puriﬁed intact nuclei were incubated with ﬂuo-3/AM (5.4 lM) for
30 min in the presence or absence of known concentration of XeB at
room temperature. Dye-loaded nuclei were washed, and centrifuged
(1000 · g for 1 min) to remove the excess of dye, and were re-sus-
pended in an internal buﬀer containing: 110 mM KCl, 10 mM
HEPES–Tris (pH 7.0), 3 mM MgCl2, 0.1 mM EGTA, 2.5 mM
ATP, 25 lM phosphocreatine (Sigma) and 5 UI ml1 of creatine
phosphokinase (Sigma). Thereafter, nuclei were stimulated with
10 lM IP3 (Calbiochem). The photometric measurements were made
in a Fluoromax-2 (ISA Instruments S.A. Inc. Jobin Yvon
Spex). Excitation and emission wavelengths were 506 and 526 nm,
respectively.
Fig. 2. Dose–response relationship for the eﬀect of XeB on the [3H]IP3
binding to cerebellar rat membranes (A) and rat myotube homoge-
nates (B). The data in A and B were corrected for non-speciﬁc binding,
measured in the presence of 1 lM IP . The 100% value represents the
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For determining ATPase activity, 6–7 days-old rat-myotube cultures
were used. Cells were rinsed in PBS solution and incubated for 15–20
min at room temperature with a solution containing 145 mM NaCl,
5 mM KCl, 1 mM MgCl2, 5.6 mM glucose, 10 mM HEPES–Na (pH
7.4) and 1–100 lMXeB. Then, the reaction was stopped by rapid aspi-
ration of the medium and the cells were homogenized using a Dounce
homogenizer and re-suspended in a solution containing 50 mM Tris–
HCl, pH 7.4, 1 mM EDTA, 1 mM b-mercaptoethanol and 0.3 M su-
crose. Ca2+-ATPase activity was calculated as the diﬀerence between
total ATPase and Mg2+-ATPase. The reaction medium to determine
Mg2+-ATPase activity contained 50 mM L-histidine (pH 7.4), 3 mM
MgCl2, 100 mM KCl, 1 mM EGTA, 4 mM ATP and 0.05–0.1 mg/ml
of protein in a ﬁnal volume of 1.0 ml. To measure the total ATPase
activity, EGTA was excluded from the medium and 0.1 mM CaCl2
was added. The reaction was started by addition of ATP and the incu-
bation was carried out at 25 C for 15 min. The reaction was stopped
by addition of 0.25 ml of 10% SDS, and then, 0.5 ml of 2.5% ammo-
nium molybdate and 0.1 ml of ELON (p-methyl amino phenol and
3% sodium sulphite) was added and mixed thoroughly. The amount
of inorganic Pi formed was calculated from a colorimetric calibration
curve [29].
2.6. Xestospongin B
Xestospongia exigua specimens were collected in Prony Bay (New
Caledonia). The isolation procedure of xestospongin B was the same
as previously described [2]. Samples were controlled with electrospray
ionization mass spectrometry (Brucker Esquire-LC ion trap; positive
mode M+H 477.4 and M+Na 499.6; negative mode M-H 475.5) and
TLC (Merck silica gel 60 F254; hexane–ET2O–MeOH–N-H4OH 20/
70/10/0.5).3
[3H]IP3 binding in the absence of XeB or XeC. For comparison, data
obtained with 3 concentrations of XeC on rat myotube homogenates
are shown. Means ± S.D. of three diﬀerent determinations are shown
in A and B.3. Results
3.1. Binding competition between XeB and radiolabelled IP3
The precise site of action for xestospongins has been a mat-
ter of controversy, probably in part because no reports of a di-
rect interaction between the alkaloids and IP3 receptors are
available. As shown in Fig. 2, we measured displacement of
[3H]IP3 from its receptor by XeB, both in rat cerebellar mem-
branes (Fig. 2A) and in rat myotube homogenates (Fig. 2B). In
both cases, XeB displaced [3H]IP3 from its receptor in a con-
centration-dependent manner. The curves were ﬁtted to a ﬁrst
order kinetics and the concentration of XeB that competes for
half the speciﬁc binding was calculated. Thus, the XeB EC50
was 44.6 ± 1.1 lM (n = 3 independent preparations) for cere-
bellar membranes, and 27.4 ± 1.09 lM (n = 3) for myotube
homogenates, with Ki values of 31 and 16 lM, respectively.
Interestingly, xestospongin C, reported as unable to displace
binding of IP3 from brain preparations at low concentrations
[7], also tended to displace IP3 binding from myotube homog-
enates in a range of concentrations similar to those of XeB
(Fig. 2B).
3.2. XeB blocks bradykinin-induced Ca2+ signalling in NG108-
15 cells
Diﬀerentiated NG108-15 cells loaded with ﬂuo-3/AM and
bathed with standard physiological solution responded to the
external application of bradykinin (1 lM) with a transient in-
crease in the cytosolic ﬂuorescence, as shown in a typical
experiment (Fig. 3A–C). The Ca2+ signal induced by bradyki-
nin (Fig. 3G) was characterized by a rapid rise in ﬂuorescence
that reached a maximum followed by a decay phase that
attained the basal ﬂuorescence level of the cells. When NG108-
15 cells were pre-treated with 27 lM XeB for 20 min, bradyki-
nin was unable to induce the characteristic transient Ca2+signal observed in control experiments as shown in Fig. 3D–
F, H, which is representative of nine diﬀerent experiments with
36 independent coverslips. The blockade of bradykinin re-
sponse by XeB was not accompanied by changes in the basal
level of ﬂuorescence when continuously monitored during a
20 min period (n = 6 independent coverslips, data not shown).
However, the blockade of bradykinin responses by XeB de-
pended on the concentration used. Two diﬀerent XeB concen-
trations (5 and 13.5 lM), applied for 20 min, reduced the
number of cells in a given coverslip that responded to bradyki-
nin by 12 ± 3.2 and 66 ± 12%, respectively (n = 6 independent
coverslips).
3.3. XeB blocks selectively a delayed Ca2+ signalling in rat
myotubes
Cultured skeletal myotubes respond to membrane depolar-
ization induced by a high K+ (47 mM) medium with two kinet-
ically distinct Ca2+ signals (Fig. 4A): (i) a fast Ca2+ transient
(lasting 1–2 s) related to excitation-contraction coupling, and
(ii) a slow Ca2+ signal, starting seconds after the fast one, that
is unrelated to contraction, and lasts several seconds [18,19].
XeB (10 and 40 lM), had little, or no eﬀect on the fast Ca2+
transient evoked by a high K+ medium (n = 4) (Fig. 4C–E).
The fact that the fast Ca2+ transient remained unaltered sug-
gests that neither ryanodine receptors, nor Ca2+ storage pools
were aﬀected by the drug. Interestingly, XeB depending on the
dose, either reduced and largely delayed the onset for the slow
Ca2+ signal (Fig. 4D), or completely blocked the slow Ca2+ sig-
nal evoked by the high K+ medium (Fig. 4B and E). These re-
sults indicate that the slow Ca2+-signal, which is unrelated to
Fig. 3. Ca2+ signals induced by the external application of 1 lM
bradykinin in NG108-15 cells and its suppression by pre-treatment
with 27 lM XeB. Images show the basal ﬂuorescence level of the cells
before (A, D), during bradykinin exposure (B, E), and 5 min after
bradykinin exposure (C, F). Time course of the relative ﬂuorescence
change of a cell exposed to bradykinin (G), and pre-treated with XeB
before the addition of bradykinin to the standard medium (H).
Distinct NG108-15 cells were used in A–C, D–F, G and H. Calibration
in F applies to all images.
Fig. 4. XeB inhibits the slow Ca2+ signal evoked by membrane
depolarization with high K+ (47 mM) medium in rat myotubes. A,
series of ﬂuorescence images in myotubes previously loaded with ﬂuo-
3/AM, before (b) and after depolarization with high K+ at the times
indicated (s). The basal ﬂuorescence (b) is shown on the top of the
panels and the following images were taken immediately after the
addition of the high K+ medium, which remained in the bath
throughout the recording. Images were acquired every 2 s and are
presented in pseudocolors. Note the fast- and slow-Ca2+ signal
transients. B, eﬀect of pre-treatment with 40 lM XeB for 20 min, in
another myotube on the fast- and slow-Ca2+ signals triggered by high
K+. Notice that XeB suppressed the slow-Ca2+ transient. C, D, and E,
time course of the relative ﬂuorescence changes, expressed with respect
to the basal ﬂuorescence, obtained in three diﬀerent myotubes after
addition of the high K+ medium at time = 0. Myotubes in D and E,
were pre-treated with 10 and 40 lM XeB, respectively. Note both the
reduction in amplitude and delayed onset of the ﬁrst component of the
slow signal (D) and complete blockade (E) of the slow-Ca2+ signal,
together with the lack of signiﬁcant eﬀect of XeB on the fast Ca2+
signal.
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3.4. XeB neither aﬀects the Ca2+ pump nor capacitative Ca2+
entry in rat myotubes
It has been reported that XeC not only inhibited IP3-induced
Ca2+ release, but also blocked the Ca2+ pump of the endoplas-
mic reticulum in various cell systems [14–16]. Therefore, in the
present study we further investigated the speciﬁcity of XeB on
Ca2+ release induced by thapsigargin, a well known blocker of
the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase pumps
[30,31]. In control rat myotubes, exposed to a Ca2+-free med-
ium, the addition of thapsigargin (0.5 lM) elicited a slow and
transient calcium signal, that reﬂects the release and depletion
of Ca2+ from the sarcoplasmic reticulum (Fig. 5A). This pro-
longed but transient Ca2+ release induced by thapsigargin
was not altered when myotubes were previously incubated,
for 20 min, with either 10 or 40 lMXeB, as shown in represen-
tative recordings (Fig. 5B and C). Similar results to those
shown in Fig. 5 have been observed in three additional exper-
iments. These results indicate that in rat myotubes XeB neither
depleted the sarcoplasmic reticulum Ca2+ stores nor prevented
thapsigargin action.
In recent years, much research has been devoted to the
mechanism linking depletion of intracellular Ca2+ stores to
the activation of plasma membrane channels (for a reviewsee [33]). Therefore, it was of interest also to determine whether
XeB aﬀected capacitative Ca2+ entry through store operated
channels after depletion of Ca2+ stores by thapsigargin. As
shown in Fig. 5A, depletion of sarcoplasmic reticulum Ca2+
stores by 0.5 lM thapsigargin, in Ca2+-free medium, was
accompanied by a fast increase in ﬂuorescence, upon addition
of 2 mM Ca2+ to the external medium (n = 3). Furthermore, as
shown in Fig. 5A–C, XeB (10 and 40 lM) did not appear to
modify Ca2+ inﬂux (as far as it can be judged by the ﬂuores-
cence measurements), which reﬂect Ca2+ entry through store
operated Ca2+ channels.
In order to further explore a possible interaction of XeB
with the calcium pump, we measured the calcium-dependent
ATPase activity on muscle cell homogenates. Ca2+ stimulated
activity, measured as the diﬀerence between total activity, in
the presence of calcium and magnesium, minus the activity
in the absence of calcium, was 0.3 lmol Pi mg protein1 min1,
and was not signiﬁcantly modiﬁed when cell homogenates were
incubated with 1, 50 and 100 lM XeB (Table 1).
Fig. 5. Lack of eﬀect of XeB on Ca2+ transients evoked by thapsi-
gargin (0.5 lM) in rat myotubes. A, relative ﬂuorescence variation in a
region of interest before and after addition of thapsigargin to the Ca2+-
free medium supplemented with EGTA (0.5 mM). When indicated by
an arrow, the external medium was replaced by one containing 2 mM
Ca2+. B, same experiment as in A, using a myotube previously treated
for 20 min with 10 lM XeB. C, same experiment as in A, using a
myotube previously treated (20 min) with 40 lM XeB.
Fig. 6. XeB blocks IP3-induced Ca
2+ oscillations in highly puriﬁed
isolated myonuclei. A, isolated myonuclei images obtained with
contrast-phase (left panel) and ﬂuorescence microscopy (right panel)
after staining with acridine orange. Calibration in A = 10 lm. B, dose–
response relationship for the eﬀect of XeB on calcium oscillations
induced by IP3 (10 lM) in a population of isolated myonuclei. The
100% value represents the frequency of IP3-induced calcium oscilla-
tions in the absence of XeB. The curve was ﬁtted to a ﬁrst order
kinetics, and the calculated EC50 was 18.9 ± 1.35 lM (n = 3 diﬀerent
determinations), with R2 = 0.9761 for a goodness-of-ﬁt.
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We have investigated the eﬀect of XeB on Ca2+ mobilization
induced by IP3, in a population of isolated rat myotube nuclei.
The advantage of this model is that isolated myotube nuclei
contain the nuclear envelope and some perinuclear endoplas-
mic reticulum, but are devoid of other cellular organelles, thus
simplifying the interpretation of results. Previous work has
shown that IP3 can release Ca
2+ from the nuclear envelope
suggesting that IP3 receptors may be localized predominantly
in the inner nuclear membrane [33,34]. The addition of
10 lM IP3 to the external medium of isolated myonuclei, pre-
viously loaded with ﬂuo-3/AM, evoked oscillatory Ca2+ signals
that could be measured during a given time period. These Ca2+
transients which reﬂect the activation of IP3 receptors in theTable 1
Eﬀect of xestospongin B on total, Mg2+- and Ca2+-ATPase activity determin
Condition Total ATPase
Control 0.383 ± 0.100
1 lM Xestospongin B 0.349 ± 0.084
50 lM Xestospongin B 0.489 ± 0.047 (\)
100 lM Xestospongin B 0.449 ± 0.054
ATPase activities were determined as described in Section 2 and are exp
means ± S.D., of n = 6 diﬀerent determinations from diﬀerent myotube cult
(P < 0.05, 0.01 and 0.03, respectively).population of nuclei were quantiﬁed under control conditions,
and after incubation with various concentrations of XeB. As
shown in Fig. 6, the alkaloid, depending on the concentration,
either reduced the frequency, or completely abolished the cal-
cium signal oscillations induced by 10 lM IP3. The curve was
ﬁtted to a single binding site and this ﬁtting was better than
that to a two-site model, indicating that the response is fairly
speciﬁc.4. Discussion
To the best of our knowledge, this is the ﬁrst study to dem-
onstrate that highly puriﬁed XeB blocks IP3-mediated Ca
2+
signalling in diﬀerentiated rodent NG108-15 cells, intact rated in rat myotube homogenates
Mg2+-ATPase Ca2+-ATPase
0.062 ± 0.026 0.321 ± 0.096
0.058 ± 0.026 0.291 ± 0.097
0.153 ± 0.041 (\\) 0.336 ± 0.071
0.134 ± 0.039 (\\\) 0.315 ± 0.109
ressed as lmol Pi mg protein1 min1. Values are presented as the
ures. (\), (\\), (\\\) Denote values signiﬁcantly diﬀerent from controls
2056 E. Jaimovich et al. / FEBS Letters 579 (2005) 2051–2057skeletal myotubes, and isolated myonuclei. Previous studies
have considered xestospongins as allosteric antagonists for
IP3 receptor, since XeC (1–10 lM) did not aﬀect the ability
of [3H]IP3 (1 nM) to bind to cerebellar microsomes, despite
blocking IP3-induced Ca
2+ release [7]. In our hands, XeC
had little or no eﬀect on IP3 binding in myotube homogenates
at sub-micro molar concentrations (0.5–1 lM) at which phar-
macological eﬀects have been reported in other systems; never-
theless, some binding displacement was evident at higher
concentrations. Our results on the inhibition of Ca2+ signals
in intact cultured cells, and the binding competition experi-
ments, in both rat cerebellar membranes and skeletal myotube
homogenates (Fig. 2), strongly suggest that XeB eﬀects can be
explained by competitive inhibition of IP3 receptors. The fact
that the apparent Ki values for displacement of [
3H]IP3 by
XeB are in the same concentration range than the EC50 for
inhibition of Ca2+ signals is indicative that the alkaloid has a
low aﬃnity for IP3 receptors. Since results obtained in intact
cultured cells lack precision in terms of the eﬀective concentra-
tion of the blocker at the active intracellular binding site,
experiments were performed on isolated rat skeletal myonuclei
in which XeB concentration could be more eﬀectively moni-
tored. Isolated myonuclei have been shown to produce Ca2+
transients upon addition of IP3 (Cardenas, Liberona, Molgo´,
Colasante, Mignery and Jaimovich, to be published). Under
this condition, XeB inhibition of Ca2+ oscillations occurred
with similar EC50 as the ones obtained for IP3 binding-dis-
placement experiments. These results further conﬁrm the low
aﬃnity XeB has for IP3 receptors.
In NG108-15 cells XeB completely blocked bradykinin-
induced intracellular Ca2+ signals (Fig. 3) that are known to
be mediated by IP3 [24,35]. A similar blockade of bradyki-
nin-induced Ca2+ signal in pheochromocytoma (PC12) cells
was previously shown with equivalent concentrations of XeC
[7]. However, in those cells, XeC was reported not only to in-
hibit Ca2+ release from IP3-sensitive Ca
2+ stores, but also from
ryanodine-sensitive Ca2+ stores [7]. In the present study we
were able to test in rat skeletal myotubes depolarized with a
high K+ medium the eﬀect of XeB in the two Ca2+ stores, ﬁnd-
ing no reduction on the fast Ca2+ signal relating Ca2+ release
from ryanodine-sensitive stores (Fig. 4). Only the slow Ca2+
signal occurring during K+-induced membrane depolarization
was aﬀected by XeB. This slow Ca2+ signal has been shown to
be related to IP3 transients and IP3 receptors [18–20], and re-
cent work suggests its implication in regulating gene expression
[21,22,25]. Thus, XeB appears rather selective for IP3-sensitive
Ca2+ stores in skeletal myotubes. Cultured skeletal muscle cells
are endowed with all three types of IP3-receptor [21], but their
relative role in Ca2+ signalling remain at present unknown, in
part due to the lack of selective antagonists for IP3 receptor
subtypes.
Despite its popularity XeC has been reported to have some
limitations in regard to its speciﬁcity. Thus, it has been sug-
gested that XeC not only inhibited IP3-induced Ca
2+ release
in permeabilized A7r5 smooth muscle cells, but also was an
equally potent blocker of the endoplasmic-reticulum calcium
pump [14]. However, subsequent studies were unable to ob-
serve any inhibitory eﬀect of XeC on caﬀeine-induced Ca2+ re-
lease, suggesting that the calcium pump was unaﬀected by the
alkaloid [36]. In the present study a lack of eﬀect of XeB on the
calcium pump of skeletal myotubes was actually shown in two
independent ways. Thus, prolonged incubation of cells with40 lMXeB did not alter Ca2+ transients induced by thapsigar-
gin in Ca2+-free medium (Fig. 5). These transients reﬂect the
Ca2+ content of intracellular stores, which are completely de-
pleted by thapsigargin [31,32]. The fact that the content of
the stores remained unchanged clearly indicates that XeB does
not inhibit the calcium pump. Furthermore, direct measure-
ments of the Ca-ATPase activity in muscle cell homogenates
(Table 1) indicated that it was not inhibited by XeB. The sole
non-speciﬁc eﬀect so far detected with XeB appeared to be a
slight enhancement of basal Mg-dependent ATPase activity.
We conclude that XeB is an eﬀective inhibitor of IP3-depen-
dent Ca2+ signals in both skeletal muscle and neuronal cells,
and isolated myonuclei and constitutes a new membrane-
permeable pharmacological tool for studying IP3-dependent
signal transduction in living cells and subcellular organelles.
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